Vascular Grafts Market

Vascular Grafts Market Outlook (2023 to 2033)

The global vascular grafts market is estimated at US$ 3.73 billion in 2023 and is predicted to climb to a value of US$ 7.04 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for vascular grafts is forecasted to rise at a healthy 6.5% CAGR over the next ten years.

Vascular grafts are applied to bypass unhealthy or diseased blood vessels. These grafts are necessary to repair damaged arteries, veins, and blood vessels as well as to replace rigid blood vessels. These grafts may be artificial, partially artificial, or derived from the body of the patient.

Primarily, shipments of vascular grafts are forecasted to be driven by the surging prevalence of cardiovascular disorders around the world. Poor eating habits, adoption of a sedentary lifestyle, and high alcohol consumption are practices leading to the growing incidence of heart diseases among people.

Rising prevalence of chronic renal diseases, aortic aneurysms, and rising cardiovascular illnesses are expected to drive market expansion. Expanding geriatric population, the launch of novel cardiovascular treatment products, rising healthcare expenditure, and increasing awareness regarding cardiovascular disorders are other prospects that could bolster vascular graft sales in the long run.

Vascular graft providers are focusing on obtaining new approvals to get their products in the marketplace and compete with other market players.

• In 2021, for Zenith’s fenestrated endovascular graft, Cook Medical obtained FDA breakthrough device designation. For fatal or permanently crippling diseases or disorders, the product offers more efficient diagnosis or treatment.

Surging popularity of minimally invasive surgical procedures and rising awareness regarding the benefits associated with the use of cardiovascular grafts are also anticipated to benefit market growth going forward. On the contrary, the dearth of skilled medical professionals to handle vascular grafts in emerging economies and the risk of vascular graft-related infections are anticipated to be major constraints for overall market development in the long run.

Report Attributes	Details
Vascular Grafts Market Size (2023)	US$ 3.73 Billion
Projected Market Value (2033F)	US$ 7.04 Billion
Global Market Growth Rate (2023 to 2033)	6.5% CAGR
Market Share of Endovascular Aneurysm Repair (EVAR) Treatments (2023)	>50%
Market Share of Hospitals (2033F)	>60%
Key Companies Profiled	Endologix Inc. OrbusNeich Cook Medical Cryolife Getinge Group LeMaitre Vascular Inc. Medtronic PLC Terumo Medical Corporation W.L. Gore & Associates Inc. Vascular Graft Solution Ltd.

Can Start-ups Forge a New Legacy in the Vascular Grafts Business Realm?

“Innovation Allowing New Vascular Graft Companies to Break Barriers”

Incoming vascular graft providers are focusing on improving the quality of cardiovascular disorder treatment by developing innovative and novel solutions.

• Founded in 2014, Cagent Vascular, a company focused on improving the quality of cardiovascular treatments, offers a novel vascular graft that is made from a synthetic material that is capable of mimicking the properties of natural tissue. The product is a more biocompatible and durable alternative to traditional vascular grafts.

Raising new funds to advance research and development of novel offerings is also a popular trend that many vascular grafts start-ups are focusing on as it also allows them to expand the horizons of their business thereby boosting revenue generation.

• In February 2023, Xeltis, a medical technology company focused on developing solutions to restore cardiovascular function, announced that it had raised US$ 35.31 million in a Series D2 equity raise. The raise was backed by the company’s current as well as some new investors. Xeltis offers aXess, which is a vascular access graft for patients suffering from CKD and requiring hemodialysis.

Next-generation tissue-engineered vascular grafts are being created as a result of technological advances to treat various vasculopathies. With this method, major problems, including intimal hyperplasia, thrombosis, and beneficial graft remodelling are properly addressed and aspiring vascular graft manufacturers can focus on this trend to make a mark in the global competitive landscape.

Start-ups can benefit by learning more about aspects such as local supply, pricing trends, product standards, safety regulations, and new developments that have been discussed extensively in this vascular grafts industry study by skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

Which Asian Countries Should Vascular Graft Suppliers Target?

“China, India, Japan – Leading Markets in APAC Region”

Rapidly rising aging population in countries such as India, Japan, and China is projected to create highly lucrative business opportunities for vascular graft manufacturers and distributors over the coming years. Governments of these countries are also focusing on creating more awareness regarding cardiovascular diseases and investing heavily in medical infrastructure development, which is also projected to benefit vascular graft sales over the coming years.

Growing availability of innovative treatment procedures, rising healthcare spending capacity, and high adoption of early diagnosis systems are other factors that could open new frontiers of opportunities for vascular graft manufacturers going forward.

Why Does the United States Have an Irresistible Appeal for Vascular Graft Suppliers?

“Growing Number of Cardiovascular Surgeries Primarily Tempting Investors”

The United States is known to have the highest incidence of cardiovascular disorders in the world and this is why the country is also home to a huge number of surgeries for the same. Poor eating habits and the adoption of sedentary lifestyles are primary causes resulting in a high incidence of cardiovascular complications in the people of the United States. The advanced healthcare infrastructure of the country facilitates a wide variety of cardiovascular treatments thereby promoting sales of vascular grafts, heart valves, tube grafts, etc.

Surging popularity and availability of minimally-invasive surgeries in the country are also forecasted to influentially augment vascular graft demand over the coming years. The high prevalence of obesity and expanding senescent population are also slated to contribute to market growth in the United States across the forecast period and beyond.

Which Market Trend is Steering Demand for Vascular Grafts in European Countries?

“Growing Popularity of Minimally Invasive Surgeries Promoting Market Growth”

Availability and popularity of minimally invasive surgeries have been increasing rapidly in European countries in recent years and this coupled with growing awareness regarding cardiovascular disorders is projected to favor vascular grafts demand going forward. Increasing penetration of advanced healthcare technologies, a rapidly rising senescent population, and high patient spending capacity are other factors contributing to soaring sales of vascular grafts and other types of stent grafts in Europe through 2033.

Germany, France, Italy, and the United Kingdom are estimated to be some of the most investment-worthy spaces in the European region throughout the forecast period for established as well as new vascular graft vendors.

Category-wise Insights

Preference for Which Treatment is High Across the World?

“Endovascular Aneurysm Repair (EVAR) Treatment Preferred Choice of Patients”

Based on treatment, the vascular grafts market is divided into endovascular aneurysm repair (EVAR), peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair (EVAR) treatments account for over 50% share of the global market at present.

Compared to open surgery, endovascular aneurysm repair provides patients with abdominal aortic aneurysms with more affordable care. Additionally, the use of endovascular aneurysm repair surgery procedures will increase due to problems associated with open repair operations.

A fabric tube known as an endovascular stent graft is held in place by a metal mesh structure called a stent. Although it can be used for several blood vessel issues, it is most frequently employed to strengthen an aneurysm, a weak area in an artery.

The need for endovascular stents is anticipated to increase as EVAR replaces traditional open thoracic aorta procedures and endovascular technology advances. Endovascular grafts also hasten healing and lessen pain compared to open chest surgeries. It also results in shorter hospital stays, broadening its appeal.

Market expansion is primarily driven by the increasing use of endovascular surgery to treat aneurysms, the preference for minimally-invasive surgery over open surgery, and the aging global population.

Where Will Vascular Graft Sales Be the Highest?

“Hospitals to Spearhead Global Revenue Generation”

Based on end user, the market is segmented into hospitals and ambulatory surgical centers.

Hospitals are projected to represent a significant share of the global vascular grafts market during the assessment period. Vascular grafts are typically used at hospitals since these facilities are eligible for government funding to cover the high cost of the equipment and services needed during an operation.

Due to heart examinations being frequently conducted in hospitals, medical technology, and healthcare corporations are prioritizing these facilities as their top distribution locations for vascular grafts.

The most popular option and ideal location for vascular access operations, from dialysis to cardiovascular, are hospitals. The demand for vascular grafts in hospitals will be fuelled by a wide range of possible treatments and the use of innovative technology that reduces post-operative problems.

Competitive Landscape

Top-tier vascular graft suppliers are focusing on expanding their business scope by raising capital to advance their R&D processes and hasten the launch of novel offerings.

• Healionics Corporation, a private clinical-stage company, announced that it had raised US$ 4.7 million in an equity financing round in May 2021. The round was led by Keiretsu Capital. The funds were expected to be used for the commercialization of its novel STARgraft vascular graft.

Key Segments of Vascular Grafts Industry Research

• By Treatment :

  • Endovascular Aneurysm Repair (EVAR)
  • Peripheral Vascular Repair
  • Hemodialysis Access

• By Raw Material :

  • Polyester
  • ePTFE
  • Polyurethane
  • Biosynthetic

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA